Capricor Therapeutics, Inc. (CAPR) Financials

$12.72

south_east
-$0.47 (-3.56%)
Day's range
$12.31
Day's range
$12.99
Profit Margin
Revenue
Earnings
$30M$30M$20M$20M$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30MEarning201720172018201820192019202020202021202120222022202320234000%4000%2000%2000%0%0%-2000%-2000%-4000%-4000%-6000%-6000%-8000%-8000%Profit Margin

CAPR Income statement / Annual

Last year (2023), Capricor Therapeutics, Inc.'s total revenue was $25.18 M, an increase of 887.79% from the previous year. In 2023, Capricor Therapeutics, Inc.'s net income was -$22.29 M. See Capricor Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $25.18 M $2.55 M $244,898.00 $310,250.00 $1.01 M $1.67 M $1.37 M $3.19 M $3.78 M $4.79 M
Cost of Revenue $1.07 M $694,871.00 $245,697.00 $8.46 M $5.14 M $12.07 M $10.77 M $16.04 M $13.76 M $7.79 M
Gross Profit $24.11 M $1.85 M -$799.00 -$8.15 M -$4.14 M -$10.40 M -$9.40 M -$12.85 M -$9.98 M -$3.00 M
Gross Profit Ratio 0.96 0.73 -0 -26.26 -4.12 -6.22 -6.87 -4.03 -2.64 -0.63
Research and Development Expenses $36.45 M $21.82 M $13.57 M $8.46 M $5.14 M $12.07 M $10.77 M $16.04 M $13.76 M $7.79 M
General & Administrative Expenses $12.37 M $10.43 M $7.61 M $5.54 M $3.60 M $4.93 M $4.76 M $4.93 M $4.37 M $3.02 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $12.37 M $10.43 M $7.61 M $5.54 M $3.60 M $4.93 M $4.76 M $4.93 M $4.37 M $3.02 M
Other Expenses $0.00 $190,582.00 $548,207.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $48.19 M $32.25 M $21.18 M $14.00 M $8.74 M $17.00 M $14.23 M $20.17 M $16.39 M $10.80 M
Cost And Expenses $49.26 M $32.25 M $21.18 M $14.00 M $8.74 M $17.00 M $14.23 M $20.17 M $16.39 M $10.80 M
Interest Income $1.73 M $0.00 $57,460.00 $32,943.00 $94,791.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $398,807.00 $344,665.00 $248,626.00 $200,505.00
Depreciation & Amortization $1.07 M $694,871.00 $245,697.00 $143,890.00 $171,956.00 $157,652.00 $144,174.00 $134,637.00 $110,865.00 $41,896.00
EBITDA -$23.01 M -$29.16 M -$20.69 M -$13.55 M -$7.56 M -$15.17 M -$12.72 M -$18.33 M -$12.50 M -$5.97 M
EBITDA Ratio -0.91 -11.84 -87 -44.23 -7.79 -9.17 -9.41 -5.32 -3.34 -1.25
Operating Income Ratio -0.96 -11.65 -85.5 -44.13 -7.7 -9.17 -9.41 -5.32 -3.34 -1.26
Total Other Income/Expenses Net $1.79 M $677,851.00 $915,922.00 $32,943.00 $92,071.00 $135,991.00 $15.29 M -$1.83 M -$245,513.00 -$198,607.00
Income Before Tax -$22.29 M -$29.02 M -$20.02 M -$13.66 M -$7.64 M -$15.19 M $2.43 M -$18.81 M -$12.86 M -$6.22 M
Income Before Tax Ratio -0.89 -11.39 -81.76 -44.02 -7.6 -9.09 1.78 -5.9 -3.4 -1.3
Income Tax Expense $0.00 -$677.85 -$613,412.00 -$176,833.00 -$264,027.00 $135,991.00 $254,633.00 $218,946.00 $137,761.00 $200,505.00
Net Income -$22.29 M -$29.02 M -$19.41 M -$13.48 M -$7.38 M -$15.19 M $2.43 M -$18.81 M -$12.86 M -$6.22 M
Net Income Ratio -0.89 -11.38 -79.25 -43.45 -7.34 -9.09 1.78 -5.9 -3.4 -1.3
EPS -0.83 -1.18 -0.84 -0.87 -1.99 -5.17 1 -10.14 -8.09 -5.31
EPS Diluted -0.83 -1.18 -0.84 -0.87 -1.99 -5.17 0.9 -10.14 -8.09 -5.31
Weighted Average Shares Out $26.78 M $24.55 M $23.09 M $15.57 M $3.71 M $2.94 M $2.32 M $1.86 M $1.59 M $1.17 M
Weighted Average Shares Out Diluted $26.78 M $24.55 M $23.09 M $15.57 M $3.71 M $2.94 M $2.68 M $1.86 M $1.59 M $1.17 M
Link